What Verdica's 799 score means for ALEMBIC LTD
Alembic Ltd's composite score of 799 out of 850 places the entity in the "strong" band (740–799), indicating above-average compliance performance across regulated pharmacy operations. This score reflects data aggregated from state board of pharmacy records, FDA submissions, and DEA compliance tracking—three primary regulatory touchstones for pharmaceutical manufacturers and distributors.
A score in this range suggests that Alembic Ltd has demonstrated consistent adherence to major regulatory requirements and has not accumulated significant compliance red flags in the indexed data sources. Readers should interpret this as a provider with a solid track record, though not yet in the highest tier (800–850, classified as "excellent"). The gap of 51 points between Alembic's score and the maximum indicates room for improvement or documented areas of minor regulatory attention.
For business owners, healthcare systems, or consumers evaluating pharmacy providers, a 799 score is a reasonable baseline for confidence. It suggests the entity is actively monitored by regulators and has not been subject to major enforcement actions that would significantly depress the score. However, the score alone does not guarantee absence of smaller violations or administrative findings; it reflects the aggregated risk profile as of the date indexed.
How the sub-scores break down
Product Approval (850/850): This perfect sub-score indicates that Alembic Ltd's pharmaceutical products have successfully navigated FDA approval pathways and meet the agency's manufacturing and quality standards for the submissions reviewed. In the pharmacy industry, a maximum approval score typically means no indexed product recalls, warning letters specific to product formulation or efficacy, or pending approval delays for core offerings. This is the strongest signal in Alembic's profile.
Manufacturer Profile (720/850): This mid-range sub-score suggests that while Alembic Ltd operates as a licensed manufacturer, there may be documented compliance observations or administrative findings in state board records or DEA filings. A score of 720 is respectable but notably lower than the product approval rating. This gap often reflects facility inspection findings, licensing requirements flagged for renewal, or procedural compliance items that do not invalidate operations but warrant regulatory note. Manufacturers typically see variation here based on facility audits and record-keeping compliance.
FDA Compliance (830/850): This near-maximum score indicates strong performance on FDA-tracked metrics, including current good manufacturing practice (CGMP) adherence, adverse event reporting, and labeling compliance. The 20-point gap from perfect suggests Alembic has not faced significant FDA enforcement but may have minor observations or corrective action requests on file. This sub-score is a primary predictor of product quality and safety posture in the regulated pharmacy space.
What regulators track for pharmacy providers
State boards of pharmacy maintain licensing records, facility inspection reports, and disciplinary actions for manufacturers and distributors. They track compliance with compounding standards, labeling accuracy, inventory control, and handling of controlled substances. FDA oversight focuses on current good manufacturing practice (CGMP), including facility design, equipment qualification, process validation, and contamination control. The agency also monitors adverse event reports, product recalls, and warning letters issued to manufacturers.
DEA compliance tracking centers on controlled substance accounting, security protocols, and record retention for scheduled pharmaceuticals. Regulators audit chain-of-custody documentation, storage security, and regulatory reporting timeliness. Infractions in these areas can range from administrative citations to suspension of manufacturing licenses, depending on severity and repeat violations.
Verdica's composite score aggregates findings across these three data sources to surface overall compliance risk.
Bottom line
Alembic Ltd's 799 score reflects strong regulatory compliance with no major red flags in indexed state, FDA, or DEA records. A business considering engagement with this provider should cross-check current licensing status, review any publicly available FDA inspection reports, and confirm that product approvals align with their specific therapeutic needs.